Background: Subclinical hypothyroidism, defined by elevated thyrotropin (TSH) and normal
free thyroxine levels, is associated with adverse pregnancy outcomes, including preterm …

Hashimoto's thyroiditis (HT) is the most prevalent autoimmune thyroid disease (ATD)
worldwide and is strongly associated with miscarriage and even recurrent miscarriage (RM) …

Background: The American Thyroid Association Guidelines on Thyroid Disease During
Pregnancy and the Postpartum (ATA Guidelines) were published in 2017, with an update …

Objective To evaluate the effect of levothyroxine therapy on pregnancy outcomes compared
with placebo or no treatment in women without overt hypothyroidism with presence of thyroid …

Women with thyroid autoimmunity (TAI), predominately characterized by increased levels of
thyroid peroxidase antibody (TPOAb), are at risk for developing pregnancy related …

Objectives To explore the role of levothyroxine (LT4) supplementation in affecting the
outcome of pregnant euthyroid women with thyroperoxidase (TPO) antibodies. Methods …

Thyroid disease during pregnancy is considered a risk factor for maternal and neonatal
complications. The prevalence of overt hypothyroidism in pregnancy ranges from 0.3 to …

Transplacental passage of maternal thyroxine (T4) is essential for the maintenance of
pregnancy and for normal fetal development, especially in the first half of gestation. Mild or …

Context Analysis of a 2-screen program for congenital hypothyroidism (CH) was performed
using differential dried-blood spot thyrotropin (bTSH) cutoffs of 10 mU/L at first screening (all …

Endocrinopathies during pregnancy constitute a challenging issue, being prevalent and
requiring appropriate management to avoid maternal and fetal complications. This review …